China Universal Asset Management Co., Ltd. Beam Therapeutics Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 16,087 shares of BEAM stock, worth $361,957. This represents 0.04% of its overall portfolio holdings.
Number of Shares
16,087
Previous 9,906
62.4%
Holding current value
$361,957
Previous $232,000
69.83%
% of portfolio
0.04%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding BEAM
# of Institutions
231Shares Held
71.8MCall Options Held
283KPut Options Held
233K-
Farallon Capital Management LLC San Francisco, CA7.91MShares$178 Million0.9% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$178 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$172 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.63MShares$172 Million1.63% of portfolio
-
Arch Venture Management, LLC Chicago, IL5.44MShares$122 Million74.72% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.58B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...